Anti-ILT5 antibodies and ILT5-binding antibody fragments

Details for Australian Patent Application No. 2011207253 (hide)

Owner Tolerx, Inc.

Inventors Apostolou, Irina; Ponath, Paul; Ponte, Joe; Rosenzweig, Michael

Agent FB Rice

Pub. Number AU-A-2011207253

PCT Pub. Number WO2011/091177

Priority 61/296,791 20.01.10 US

Filing date 20 January 2011

Wipo publication date 28 July 2011

International Classifications

C07K 16/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/00 Medicinal preparations containing antigens or antibodies

Event Publications

16 August 2012 PCT application entered the National Phase

  PCT publication WO2011/091177 Priority application(s): WO2011/091177

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011207257-Immunoregulation by anti-ILT5 antibodies and anti-ILT5-binding antibody fragments

2011207241-Wellbore filter screen and related methods of use